日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: Integrated in vitro and in silico analyses

坎地沙坦酯作为鼻咽癌的再利用治疗候选药物:体外和计算机模拟综合分析

Ngernsombat, Chawalit; Suriya, Utid; Udompaisarn, Somsiri; Panomchoeng, Natta; Janvilisri, Tavan

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

利用 FDA 批准的靶向 FZD10 的药物治疗鼻咽癌:来自分子动力学模拟和实验验证的启示

Ngernsombat, Chawalit; Suriya, Utid; Prattapong, Pongphol; Verma, Kanika; Rungrotmongkol, Thanyada; Soonkum, Thananya; Kuhaudomlarp, Sakonwan; Janvilisri, Tavan

Transcriptomic profiling revealed FZD10 as a novel biomarker for nasopharyngeal carcinoma recurrence

转录组分析揭示FZD10是鼻咽癌复发的一种新型生物标志物

Tulalamba, Warut; Ngernsombat, Chawalit; Larbcharoensub, Noppadol; Janvilisri, Tavan

WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma

WNT8B作为鼻咽癌的独立预后标志物

Ngernsombat, Chawalit; Prattapong, Pongphol; Larbcharoensub, Noppadol; Khotthong, Krittika; Janvilisri, Tavan

Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis

Epstein-Barr病毒介导的信号通路在鼻咽癌发生中的作用

Richardo, Timmy; Prattapong, Pongphol; Ngernsombat, Chawalit; Wisetyaningsih, Nurulfitri; Iizasa, Hisashi; Yoshiyama, Hironori; Janvilisri, Tavan

CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line

CRISPR/Cas9 介导鼻咽癌细胞系中 SRPK1 和 SRPK2 双敲除

Pongphol Prattapong, Chawalit Ngernsombat, Sathid Aimjongjun, Tavan Janvilisri

CD2068 potentially mediates multidrug efflux in Clostridium difficile

CD2068 可能介导艰难梭菌中的多药外排

Chawalit Ngernsombat, Suthasinee Sreesai, Phurt Harnvoravongchai, Surang Chankhamhaengdecha, Tavan Janvilisri